History and progress of hypotheses and clinical trials for Alzheimer's disease

PP Liu, Y Xie, XY Meng, JS Kang - Signal transduction and targeted …, 2019 - nature.com
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive
memory loss along with neuropsychiatric symptoms and a decline in activities of daily life. Its …

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

BV Zlokovic - Nature Reviews Neuroscience, 2011 - nature.com
The neurovascular unit (NVU) comprises brain endothelial cells, pericytes or vascular
smooth muscle cells, glia and neurons. The NVU controls blood–brain barrier (BBB) …

Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery

SG Patching - Molecular neurobiology, 2017 - Springer
Glucose transporters (GLUTs) at the blood-brain barrier maintain the continuous high
glucose and energy demands of the brain. They also act as therapeutic targets and provide …

Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging

JE Ahlskog, YE Geda, NR Graff-Radford… - Mayo clinic …, 2011 - Elsevier
A rapidly growing literature strongly suggests that exercise, specifically aerobic exercise,
may attenuate cognitive impairment and reduce dementia risk. We used PubMed (keywords …

Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in A lzheimer's Disease

JD Sengillo, EA Winkler, CT Walker… - Brain …, 2013 - Wiley Online Library
Neurovascular dysfunction contributes to A lzheimer's disease (AD). Cerebrovascular
abnormalities and blood–brain barrier (BBB) damage have been shown in AD. The BBB …

Cognitive frailty, a novel target for the prevention of elderly dependency

Q Ruan, Z Yu, M Chen, Z Bao, J Li, W He - Ageing research reviews, 2015 - Elsevier
Frailty is a complex and heterogeneous clinical syndrome. Cognitive frailty has been
considered as a subtype of frailty. In this study, we refine the definition of cognitive frailty …

Early adult to midlife cardiovascular risk factors and cognitive function

K Yaffe, E Vittinghoff, MJ Pletcher, TD Hoang… - Circulation, 2014 - Am Heart Assoc
Background—Studies have linked midlife and late-life cardiovascular risk factors (CVRFs) to
cognitive function, yet little is known about CVRF exposure in early adulthood and …

Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin

CC Hsu, ML Wahlqvist, MS Lee… - Journal of Alzheimer's …, 2011 - content.iospress.com
To determine incidence of dementia in type 2 diabetic (T2DM) patients, and whether there
are adverse or favorable effects of oral agents (OA) in DM, we obtained a representative …

Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease

P Grammas - Journal of neuroinflammation, 2011 - Springer
Alzheimer's disease (AD) is an age-related disorder characterized by progressive cognitive
decline and dementia. Alzheimer's disease is an increasingly prevalent disease with 5.3 …

The utility of cerebral blood flow as a biomarker of preclinical Alzheimer's disease

CC Hays, ZZ Zlatar, CE Wierenga - Cellular and molecular neurobiology, 2016 - Springer
There is accumulating evidence suggesting that changes in brain perfusion are present long
before the clinical symptoms of Alzheimer's disease (AD), perhaps even before amyloid-β …